Apogee Therapeutics, Inc.

Q4 2025 13F Holders

Symbol
APGE
CUSIP
03770N101
Type
Equity
Class
COM
Num filings
219
Total reported value, excl. options
$5.34 B
Manager Report Date Value ($000) Shares Option Type